Search Results 391-400 of 15015 for blueberry
A single-cycle adenovirus vaccine platform co-developed by Michael A. Barry, Ph.D., at Mayo Clinic will target multiple infectious diseases and cancer.
Mayo Clinic's world-renowned infectious disease researchers study new antimicrobics, investigate patterns and mechanisms of antimicrobial resistance, track ...
About this study. Levels of bladder cancer-derived extracellular vesicles become undetectable after radical cystectomy in patients with localized bladder ...
Veliparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as carboplatin, work in ...
Mayo Clinic specialists use the latest technology to treat the full range of benign neoplasms, including complex tumors. A multidisciplinary team helps ...
Dasatinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy work in different ways to stop ...
Everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as bevacizumab, can interfere ...
Endothelial dysfunction appears to be caused by both sleep disordered breathing and obesity. As endothelial dysfunction is among the first clinical marker that ...
About this study. The purpose of this study is to identify blood cell-specific DNA methylation and micro RNA markers in tissue and stool samples in patients ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Their crucial work saves lives every day. Let Mayo Clinic researchers know they’re appreciated with a quick message.